Promental Health

Pre Diagnostics

This company develops intracellular blood tests and biomarker analytical services for the early detection of Alzheimer's disease for patients, practitioners and researchers.

ADmit Therapeutics

ADmit Therapeutics develops blood-based epigenetic tests for early Alzheimer's disease detection to assist pharmaceutical companies and healthcare providers with clinical trials and patient care.

Circular Genomics

This company develops circular RNA blood tests for diagnosing neurological and psychiatric disorders for healthcare providers, researchers and pharmaceutical organisations.

Alzeca Biosciences

This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.

MindAhead

This company develops a digital therapy application for individuals with mild cognitive impairment and dementia to slow cognitive decline.

Neurotrack

Neurotrack develops digital cognitive assessment tools and health programmes for healthcare providers and pharmaceutical companies to detect and manage Alzheimer's disease.

Mindmore

This company provides a digital platform for automated cognitive testing to healthcare clinics and patients with conditions affecting brain function.

Optina Dx

The company develops an artificial intelligence platform and retinal imaging camera for the non-invasive detection of Alzheimer's disease and other systemic conditions for healthcare providers.